CIK 0001703647
- Non-accelerated filer
- Smaller reporting company
Korro Bio, Inc.
Sign in to watch- Ticker
- KRRO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472324450
- Phone
- +1 617-468-1999
- Business address
- 60 FIRST STREET, 2ND FLOOR, SUITE 250, CAMBRIDGE, MA, 02141
- Former names
- Frequency Therapeutics, Inc.
- Open-market buys, last 90 days
- $884,752
- in 1 filing
- Open-market sales, last 90 days
- $2,161,962
- in 6 filings, $2.2M under 10b5-1 plans
Net −$1,277,210. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-17 | Arnold Wendy S Chief People Officer | Sale | −1,118 | $4.19 | $5K | 14,359 |
| 2022-02-17 | Arnold Wendy S Chief People Officer | Grant or award · Restricted Stock Unit | +150,000 | 150,000 | ||
| 2022-02-16 | PFREUNDSCHUH PETER P. Chief Financial Officer | Sale | −1,229 | $4.43 | $5K | 13,169 |
| 2022-02-16 | Loose Christopher R. Chief Scientific Officer | Sale | −851 | $4.43 | $4K | 37,770 |
| 2022-02-16 | LeBel Carl Chief Development Officer | Sale | −831 | $4.43 | $4K | 14,070 |
| 2022-02-16 | McCubbin Quentin Chief Manufacturing Officer | Sale | −1,233 | $4.43 | $5K | 27,069 |
| 2022-02-16 | Arnold Wendy S Chief People Officer | Sale | −1,057 | $4.43 | $5K | 15,477 |
| 2022-02-15 | LeBel Carl Chief Development Officer | Sale | −844 | $4.33 | $4K | 14,901 |
| 2022-02-15 | McCubbin Quentin Chief Manufacturing Officer | Sale | −1,261 | $4.33 | $5K | 28,302 |
| 2022-02-15 | Loose Christopher R. Chief Scientific Officer | Sale | −863 | $4.33 | $4K | 38,621 |
| 2022-02-15 | PFREUNDSCHUH PETER P. Chief Financial Officer | Sale | −1,347 | $4.33 | $6K | 14,398 |
| 2022-02-15 | Arnold Wendy S Chief People Officer | Sale | −1,168 | $4.33 | $5K | 16,534 |
| 2022-02-14 | LeBel Carl Chief Development Officer | Option exercise | +15,000 | 15,745 | ||
| 2022-02-14 | LeBel Carl Chief Development Officer | Option exercise · Restricted Stock Unit | −15,000 | 15,000 | ||
| 2022-02-14 | McCubbin Quentin Chief Manufacturing Officer | Option exercise | +17,500 | 29,563 | ||
| 2022-02-14 | McCubbin Quentin Chief Manufacturing Officer | Option exercise · Restricted Stock Unit | −17,500 | 17,500 | ||
| 2022-02-14 | Loose Christopher R. Chief Scientific Officer | Option exercise | +15,000 | 39,484 | ||
| 2022-02-14 | Loose Christopher R. Chief Scientific Officer | Option exercise · Restricted Stock Unit | −15,000 | 15,000 | ||
| 2022-02-14 | PFREUNDSCHUH PETER P. Chief Financial Officer | Option exercise | +15,000 | 15,745 | ||
| 2022-02-14 | PFREUNDSCHUH PETER P. Chief Financial Officer | Option exercise · Restricted Stock Unit | −15,000 | 15,000 |
Page 21 of 23 · 441 trades